Supplementary Figures from RANKL-Targeted Combination Therapy with Osteoprotegerin Variant Devoid of TRAIL Binding Exerts Biphasic Effects on Skeletal Remodeling and Antitumor Immunity
Open Access
- 3 April 2023
- other
- Published by American Association for Cancer Research (AACR)